Phase I Study of PDR001 in Patients With Advanced Malignancies.
Clinical trial NCT02678260 · COMPLETED
Trial details
- NCT number
- NCT02678260
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-19
- Primary completion
- 2017-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.